$B!!!!(B$B!!!!(B$B!!!!(B$B!!!!(B$B!!!!(B
Reference
BIOCHEMISTRY & MOLECULAR BIOLOGY
A.S.B.M.B
$B!!!!(B
$B!!!!(B$B!!!!(B
DR.HIROYUKI OHYAMA$B!J(BPh.D$B!K(B
1)
Age-related difference in synaptosomal membrane
fluidity
Hiroyuki Ohyama, Midori Hiramatsu, Norio
Ogawa, Akitane Mori
Biochemistry and Molecular Biology International
37,133-140,1995
Department of Neuroscience, Institute of
Molecular and Cellular Medicine, Okayama
University Medical
School, 2-5-1 Shikatacho, Okayama 700, Japan
and *Division of Medical Science, Institute
for Life
Support Technology, Yamagata Technopolis
Foundation, Yamagata 683 Kurumanomae, Numagi,
Yamagata 990, Japan
ACKNOWLEDGEMENTS
We thank Dr. Lester Packer of the University of California, Berkeley,
for reading our manuscript and providing us with valuable comments.
Special Thanks.
Dr. Lester Packer
Building 20 - 251 LSA
Energy & Environment Division
Lawrence Berkeley Laboratory
University of California
Berkeley, CA 94720
2)
Effect of Japanese herbal medicine(TJ-960)
on neuronal membrane fluidity of mice
Hiroyuki Ohyama, Midori Hiramatsu, Rei Edamatsu,
Akitane Mori
Magnetic Resonance in Medicine 6, 279-281,
1995
3)
Effect of Japanese herbal medicine(TJ-960),
on aging
Midori Hiramatsu, Rei Edamatsu, Hiroyuki
Ohyama, Akitane Mori
Lipid-Soluble Antioxidants:Biochemistry and
Clinical Applications.
pp.535-552,Birkhauser Verlag,Basel,1992
4)
Combined treatment of Japanese herbal medicine(TJ-960)with
low dose of dipropylacetate increased the
latent time for
pentylenetetrazol induced convulsion and
decreased brain lipid peroxidation in mice.
Hiramatsu,M., Liu J, Edamatsu,R., Kadowaki,D.,
Hamada,H., Ohyama,H., Watanabe,S., Mori,A.
Neuroscience 18, 71-76,1992
5)
Estimation of nitric oxide and nitric oxide
synthase activity in SAMP8 mouse brain
Habu,H., Yokoi,I., Kabuto,H., Ohyama,H.,
Mori,A., Teraoka,H., Komaru,N.
in: The SAM Model of Senescence (T.Takeda,
ed.) pp.343-346,Elsevier Science B.V., Amsterdam,
1994
6)
Age-related changes in nitric oxide content
and nitric oxide synthase activity
in senescence-accelerated mouse (SAM P8)
brain
Yokoi,I., Inada,K., Habu,H., Kabuto,H., Mori,A.,
Ohyama,H., Iwaya,K., Koyama,S., Nishijima,Y.,
Nishijima,K.
in: Oxidative Stress and Aging (R.G.Cutler,
L.Packer, J.Bertram, A.Mori, eds.)
pp387-391, Birkhauser Verlag, Basel, 1995
7)
UNESCO / Costam Workshop on Lipid-soluble
Antioxidants in Biochemistry of Nutrition
and Environmental Health
1991.9.21 (Malaysia)
Effect of Japanese herbal medicine(TJ-960),
on aging
Midori Hiramatsu, Rei Edamatsu, Hiroyuki
Ohyama, Akitane Mori
8)
Society for Free Radical Research 1991.9027
(Paris)
Japanese herbal medicine(TJ-960) affected
free radicals, SOD activity,
lipid peroxidation and neurotransmitter in
aged rat brain
Midori Hiramatsu, Rei Edamatsu, Hiroyuki
Ohyama, Akitane Mori
9)
5th International Congress on Oxygen Radicals
1991.11.18 (Kyoto)
Decreased membrane fluidity in rat synaptosomes
induced by active oxygen species,
guanidino compounds and convulsants
Midori Hiramatsu, Rei Edamatsu, Hajime Hamada,
Hiroyuki Ohyama, Akitane Mori
10)
5th International Congress on Oxygen Radicals
1991.11.20 (Kyoto)
Antioxidant effects of the extracts of gastrodia
fleta bl. and uncaria rhynchophylla (MJQ)
jacks
Jiankang Liu, Hajime Hamada, Hiroyuki Ohyama,
Akitane Mori.
11)
The First International Conference on Senescence:
The SAM Model 1994.3.17 (Kyoto)
Estimation of nitric oxide and nitric oxide
synthase activity in SAMP8 mouse brain
Habu,H., Yokoi,I., Kabuto,H., Ohyama,H.,
Mori,A., Teraoka,H., Komaru,N.
12)
The First International Conference on Oxidative
Stress and Aging 1994.3.25 (Hawaii)
Age-associated changes in nitric oxide (NO)
content and nitric oxide synthase (NOS) activity
in senescence accelerated mouse (SAM P8)
brain
Yokoi,I., Inada,K., Habu,H., Kabuto,H., Mori,A.,
Ohyama,H., Iwaya,K., Koyama,S., Nishijima,Y.,
Nishijima,K.
13)
International Conference on Bioradicals Detected
by ESR Spectroscopy 1994.6.13 (Yamagata)
Effect of Japanese herbal medicine(TJ-960)
on neuronal membrane fluidity of mice
Hiroyuki Ohyama, Midori Hiramatsu, Rei Edamatsu,
Akitane Mori
14)
International Symposium on Natural Antioxidants:
Molecular Mechanisms and Health Effects (ISNA)
1995.6.21 (Beijin)
Antioxidant defenses of Japanese herbal medicine(TJ-960)
, against free radical induced neural cell
damages
Akitane Mori, Hajime Hamada, Hiroyuki Ohyama,
Midori Hiramatsu, Seiichi Shinohara
Reference
1)
Mixed Japanese Herbs and Age-Related Neuronal
Functions
Midori Hiramatsu and Makiko Komatsu
Antioxidant Food Supplements in Human Health,edited
by Lester Packer,
Midori Hiramatsu,Toshikazu Yoshikawa,pp.412-428,1999
2)
Effects of Japanese herbal medicine(TJ-960),
on neuronal membrane fluidity of mice
Hiroyuki Ohyama,Midori Hiramatsu,Rei Edamatsu,Akitane
Mori.
Magnetic Resonance in Medicine 6,279-281,1995
3)
Antioxidant effect of TJ-960, a Japanese
herbal medicine, against free radical-induced
neuronal cell damage
Akitane Mori, Hajime Hamada, Hiroyuki Ohyama,
Midori Hiramatsu, Seiichi Shinohara
International Symposium on Natural Antioxidants:
Molecular Mechanisms and Health Effects(ISNA),pp.45-53.1996
4)
Effect of TJ-960 on generalized seizure in
amygdaloid kindled cats
Susumu Iizuka, Atsushi Ishige, Kyoji Sekiguchi,
Akira Sugimoto, Kouichi Itoh, Masaki Aburada,
Eikichi Hosoya, Eiichi Sugaya
Recent Advances in the Pharmacology of Kampo
Medicines pp.62-68,1988
5)
Normalizing effect of SK commercial formula
on cytochalasin-B distorted neurites using
primary cultured neurons of rat cerebeal
cortex
Aiko Sugaya, Mitsutoshi Yuzurihara, Tadashi
Tsuda, Eiichi Sugaya
J. Ethnopharmacol., 21: 193-199,1987.
6)
Effect of Kampo Medicine Preparations Using
the Pathological Model of Dementia
Michihiro Fujiwara
Brain Research Conference for Japanese Kampo
Medicine pp.67-81,1990
7)
Estimation of nitric oxide and nitric oxide
synthase activity in SAMP8 mouse brain
Habu,H.,Yokoi,I.,Kabuto,H.,Ohyama,H.,Mori,A.,Teraoka,H.,Komaru,N.
The SAM Model of Senescence(T.Takeda,ed.)
pp.343-346,
Elsevier Science B.V.,Amsterdam,1994
8)
Mixed Natural Antioxidants
Hiramatsu,M.
Food and Free Radicals,edited by Hiramatsu
et al.
Plenum Press,New York,pp.113-117,1997
DR.HIROYUKI OHYAMA$B!J(BPh.D$B!K(B
BIOCHEMISTRY & MOLECULAR BIOLOGY
HIGHER NERVOUS SYSTEM
KAMPO MEDICINE
Dr. HIROYUKI OHYAMA.$B!J(BPh.D$B!K(B
1999
$BBg;3=!GlElMN0e3X5-G04[o*5d<#NE<<(B
($BElMN0e3X!"4AJ}Lt!"o*5d!"NW>2?4M}3X!K(B
$BBg;34AJ}F2Lt6I!"Bg;3o*5d1!(B
$B7r9/AjCL$*?=$79~$_%U%)!<%`(B
$B!!(B$B!!(B
$BElMN0e3X!J4AJ}Lt!&o*5d!K@lLg!!Bg;34AJ}F2Lt6I!JF1o*5d<#NE<
$B8=:_!"@>MN0e3XC1FH$G$O
$BElMN0e3X!J4AJ}Lt!&o*5d!K!&<+A3NEK!!&Jd40BeBXNEK!$NNO$r3hMQ$7$F8z2L$r>e$2$F$$$/!"(B
$BE}9g0eLt3X!"E}9gNEK!$,!"Bg;34AJ}F2Lt6I!JF1o*5d<#NE<
$BBg;34AJ}F2Lt6I!JF1o*5d<#NE<
$BEl@>$N1QCN!J2a5n$+$i8=Be$^$G$N0e3XLt3X0eNE>pJs!a4AJ}Lt!&o*5d$N8EE5!"@.=q!"4AJ}Er:^$N;HMQ7P83!"8=Be$NNW>27P83!"Jd40BeBXNEK!$NNW>27P83!K(B
$B$r=8$a$F!":G$bM-8z$H9M$($i$l$kElMN0e3X!J4AJ}Lt!&o*5d!K!"<+A3NEK!!"Jd40BeBXNEK!$rDs6!$9$k$3$H$G$9!#(B
$BBg;34AJ}F2Lt6I!JF1o*5d<#NE<
$B?@7PaVDK!JK}@-aVDK!&DK3P2aIR>uBV!&@~0]6ZDK>I!&?@7P>c32@-aVDK!K$dG>7l4I>c328e0d>I!"=E>I6ZL5NO>I$J$I$N?@7P<@45!"(B
$B4X@a%j%&%^%A$d%7%'!<%0%l%s>I8u72$J$I$Ng186IB!"5$4I;YSCB)$J$I$NK}@-8F5[4o<@45!"DYag@-BgD21j$d%/%m!<%sIB!"%"%H%T!<@-HiIf1j$J$I<+8JLH1V<@45(B
$B$N45I>u$,0BDj$7$J$$J}!9!"99G/4|>c32$dITG%>I$N$h$&$J=w@-FCM-$NIB5$$J$I$N45
$B@>MN0e3XE*<#NE$@$1$G$O=
$B$^$?!"9bNpI$dJb9T:$Fq!"GY1j!"Nd$(!"$7$S$l!"GSG">c32$J$IG/Np$H6&$KA}$($F$/$kIB5$$N45
$B7+$jJV$7$^$9$,!"Bg;34AJ}F2Lt6I!JF1o*5d<#NE<
$B8=:_!"@>MN0e3XC1FH$G$O
$BElMN0e3X!J4AJ}Lt!&o*5d!K!"<+A3NEK!!"Jd40BeBXNEK!$NNO$r3hMQ$9$kE}9g0eLt3X!"E}9gNEK!$N3NN)$rL\;X$7$F$$$^$9!#(B
$B4pK\E*$K!"$I$NMM$J<@45$N$4AjCL$b$*o$KM-8z@-$,9b$$<@45$H$"$^$j8z2L$,4|BT$G$-$J$$<@45$,$"$k$3$H$b;v
$B$=$3$G!"Bg;34AJ}F2Lt6I!JF1o*5d<#NE<e$2$F$$$k<@45$r$$$/$D$+$4>R2p$7$^$9!#(B
$B-!G'CN>I!J%"%k%D%O%$%^!7l4I@-G'CN>I!"%l%S!<>.BN7?G'CN>I!"A0F,B&F,7?G'CN>I!J%T%C%/IB!K!"%Q!<%-%s%=%sIB!"$F$s$+$s!K(B
$BFC$K!"G'CN>I!"$F$s$+$s$N45I>u$N2~A1!"(BQOL$B!J@83h$Ne$K8z2L$r>e$2$F$$$^$9!#(B
$B9bNpI$G$O!"J*K:$l$NB>$K@:?@E*$KIT0BDj$K$J$k!"J*$r
$B$"$k$O$:$N$J$$J*$,8+$($F61$($k!"$J$IMM!9$J0[>o$J@:?@>I>u$,H/>I$7$F45
$B$3$NMM$J45$rR2p!K$,6K$a$FM-8z$G$"$j$^$9!#(B
$B-"G>7l4I>c32!JG>9<:I!"G>=P7l!"$/$bKl2<=P7l!K8e0d>I(B
$BFC$K!"G>7l4I>c32!JG>9<:I!"G>=P7l!"$/$bKl2<=P7l!K8e0d>I$d?@7PFqIB$KH<$&Sk2<>c32$K8z2L$r>e$2$F$$$^$9!#(B
$BG>7l4I>c32$d%Q!<%-%s%=%sIB$J$I$N?@7P<@45$G$OJ*$,H~L#$/?)$Y$i$l$J$$!VSk2<>c32!W$,@8$8$d$9$/!"$=$l$K$h$C$FGY1j$r5/$3$7$?$j0_aq$r:n$k$3$H$,$"$j$^$9!#(B
$B$3$NMM$J452F8|KQEr9gIzNa0{2C8:J}!"B>1~MQ=hJ}!W(B
$B$do*5d7PMm%D%\NEK!(B($BB@l0!"B-;0N$!"B>1~MQ7j!K$X$N;\=Q$,M-8z$G$"$j$^$9!#(B
$B-#K}@-8F5[4o<@45!J(BChronic Respiratory Disease,
CRD$B!K(B
$B!aK}@-JD:I@-GY<@45(B(COPD)$BGY5$I!"K}@-6;Kl<@45!"?PGY!"GY9%;@5eA}B?>I!"GY:I@r>I!"%5%k%3%$%I!<%7%9!"?gL2L58F5[>I8u72!"GY@-?4!"(B
$B5$4I;Y3HD%>I$J$I$N5^@-A}0-$NM=KI!"K}@-8F5[4o<@45$G$O!"Iwu$,A}0-$7!"$=$N7+$jJV$7$G
$B$3$NMM$J451~MQ=hJ}!W$,M-8z$G$"$j$^$9!#(B
$B$3$&$7$?45
$B-%3F
$B0\M=KI!K!"4KOB%1%"!"@83h$N
$B1dL?!aM\@8!J$h$&$;$$!aL?$rM\$$?-$P$9!a:G8e$^$GDL>o$N@83h$rB3$1$J$,$i!V$,$s$H6&B8!W
$BJd40BeBX0eNE(B $B!J(BCAM=Complementary and Altemative
Medicine$B!K$N2r@b(B
2015. 4$B!A(B
$B!JJ?@.#2#7G/#47n!K(B
$BBg;34AJ}F2Lt6I!JF1o*5d<#NE<
$B2,;3Bg3X0e3XGn;N!JJ,;R:YK&0e3X8&5f;\@_?@7P>pJs3X!"G>Be
$BFAEgBg3XLt3X=$;N!J0eNE@8L?Lt3X!!@=Lt2=3X!!@8J*LtIJ2=3X!K(B
$BBg;3Gn9T(B
Dr. HIROYUKI OHYAMA,Ph.D.
$B!!!!(B$B!!!!(B$B!!!!(B
BIOCHEMISTRY & MOLECULAR BIOLOGY
$B!!!!(B$B!!!!(B$B!!!!(B$B!!!!(B$B!!!!(B
References $B#1(B
(1) Whitehouse P.J., Price D.L. and Struble
R.G. Alzheimer's disease and senile dimentia:
loss of neurons in the basal forebrain. Science
215, 1237-1239, 1982.
(2) Price D.L., Whitehouse P.J. and Struble
R.G. Alzheimer's diseases. Ann. Rev. Med.
36, 349-356, 1985.
(3) Appleyard M.E., Smith A.D., Wilcock G.K
and Esiri M.M. Decreased CSF acetylcholinesterase
activity in Alzheimer's disease. Lancet 20,
452, 1983
(4) Lovell M.A., Ehmann W.D., Butler S.M.
and Markesbery W.R. Elevated thiobarbituric
acid reactive substances and antioxident
enzyme activity
in the brain in Alzheimer's disease. Neurology
45, 1594-1601, 1995.
(5)Mutisya E.M., Bowling A.B. and Beal M.F.
Cortical cytochrome oxidase activity is reduced
in Alzheimer's disease. J. Neurochem. 63,
2179-2184, 1994.
(6) Hensley K., Carney J.M., Mattson M.P.,
Aksenova M., Harris M., Wu J.F. and Floud
R.A. A model for $B&A(B-amyloid aggregation and
neurotoxicity based
on free radical generation by the peptide:
Relevance to Alzheimer disease. Proc. Natl.
Acad. Sci. USA 91, 3270-3274, 1994.
(7) Kasai H. and Nishimura S. Hydroxylation
of deoxyguanosine at the C-8 position by
ascorbic acid and other reducing agents.
Nucleic Acids Res. 12, 2137-2145, 1984.
(8) Shibutani S., Takeshita M. and Grollman
A.P. Insertion of specific nases during DNA
synthesis past the oxidation damage base
8-oxodG. Nature 349, 431-434, 1991.
(9) Cheng K.C., Cahill D.S., Kasai H., Nishimura
S. and Loeb L.A. 8-Hydroxyguanine, an abundant
form of oxidative DNA damage,
causes G$B"*(BT and A$B"*(BC substitutions. J. Biol.
Chem. 267, 166-172, 1992.
(10) Prasad G.S., Lovell M.A. and Markesbery
W.R. Increased nuclear DNA oxidation in the
brain in Alzheimer's diseases. J. Neurochem.
71, 2034-2040, 1998.
(11) Sohal R.S., Agarwal S. and Sohal B.H.
Oxidative stress and aging in the Mongolian
gerbil (Meriones unquiculatus). Mech. Ageing
and Dev. 81, 15-25, 1995.
(12) Asuncion J.G., Millan A., Pla R., Bruseghini
L, Esteras A., Pallardo F.V., Sastre J. and
Vina J. Mitochondrial glutathione oxidation
correlates
with age-associated oxidative damage to mitochondrial
DNA. FASEB J. 10, 333-338, 1996.
(13) Sastre J., Millan A., Asuncion J.G.,
Pla R., Juan G., Pallardo F., O'Conner E.,
Martin J.A., Droy-Refaix M.T. and Vina J.
A Ginkgo biloba extract (EGb 761)
prevents mitochondrial aging by protecting
against oxidative stress. Free Rad. Biol.
Med. 24, 298-304, 1998.
(14) Mecocci P., Fano G., Fulle S., MacGarvey
U., Shinobu L., Polidori M.C., Cherubini
A., Vecchiet J., Senin U. and Beal M.F. Age-dependent
increases
in oxidative damage to DNA, lipids, and proteins
in human skeletal muscle. Free Rad. Biol.
Med. 26, 303-308, 1999.
(15) Ciani E., Groneng L., Voltattorni M.,
et al. Inhibition of free radical production
or free radical scavenging protects from
the excitotoxic cell death mediated
by glutamate in cultures of cerebellar granule
neurons., Brain Res. 728, 1-6, 1996.
(16) Dawson V.L. and Dawson T.M. Free radicals
and neuronal cell death. Cell Death and Differentiation
3, 71-78, 1996.
(17) Pillot T., Drouet B., Queille S., Labeur
C., Vandekerckhove J., Rosseneu M., Pincon-Raymond
M. and Chambaz J.
The nonfibrillar amyloid _-peptide induces
apoptotic neuronal cell death: Involvement
of its c-terminal fusogenic domain. J. Neurochem.
73, 1626-1634, 1999.
(18) Herbison A.E., Augood S.J. and Slmonian
S.X. Regulation of GABA transport activity
and mRNA expression
by estrogen in rat preoptic ares. J. Neurosci.
15, 8302-8309, 1995.
References 2
1. Chartier-Harlin,M.C. et al. Early-onset
Alzheimer's disease caused bymutations at
codon precursor protein gene. Nature 353,
844-846 (1991).
2. Sherrington,R.et al. Cloning of a gene
bearing missense mutations inearly-onset
familial Alzheimer's disease. Nature 375,
754-760 (1995).
3. Rogaev,E.I. et al. Familial Alzheimer's
disease in kindreds withmissense mutations
in a gene on chromosome 1 related to the
Alzheimer'sdisease type 3 gene. Nature 376,
775-778 (1995).
4. Borchelt,D.R. et al. Familial Alzheimer's
disease-linked presenilin 1variants elevate
Abeta1-42/1-40 ratio in vitro and in vivo.
Neuron 17,1005-1013 (1996).
5. Duff,K. et al. Increased amyloid beta42
(43) in brains of miceexpressing mutant presenilin
1. Nature 383, 710-713 (1996).
6. Nakano,Y.et al. Accumulation of murine
amyloid beta42 with a gene-dosagedependent
manner in PS1 'knock-in' mice. Eur.J.Neurosci.
11, 2577-2581(1999).
7. Iwatsubo,T. et al. Visualization of A?42
(43) and A?40 in senileplaques with end-specific
A?monoclonals: evidence that an initiallydeposited
species is A?42 (43). Neuron 13, 45-53 (1994).
8. Scheuner,D. et al. Secreted amyloid beta-protein
similar to that in thesenile plaques of Alzheimer's
disease is increased in vivo by thepresenilin
a and 2
and APP mutations linked to familial Alzheimer'sdisease.
Nature Med. 2, 864-870 (1996).
9. Wong,P.C. et al. Presenilin 1 is required
for Notch and Dll1 expressionin the paraxial
mesoderm. Nature 387, 288-292 (1997).
10. Davis,J.A. et al. An Alzheimer's disease-linked
PS1 variant rescues thedevelopmental abnormalities
of PS1-deficient embryos. Neuron 20, 603-609(1998).
11. De Strooper,B. et al. Deficiency of presenilin-1
inhibits the normalcleavage of amyloid precursor
protein. Nature 391, 387-390 (1998).
12. Wolfe,M.S. et al. Two transmembrane aspartates
in presenilin-1required for presenilin endoproteolysis
and gamma-secretase activity.Nature 398,
513-517 (1999).
13. Guo,Q.et al. Alzheimer's presenilin mutation
sensitizes neural cells toapoptosis induced
by trophic factor withdrawal
and amyloid?-peptide:involvement of calcium
and oxyradicals. J.Neurosci. 17, 4212-4222
(1997).
14. Guo,Q.et al. Increased vulnerability
of hippocampal neurons toexcitotoxic necrosis
in presenilin-1 mutant knock-in mice. Nature
Med. 5,101-106 (1999).
15. Sidrauski,C.et al. The unfolded protein
response: an intracellularsignalling pathway
with many surprising features. Trends in
Cell Biol. 8,245-249 (1998).
16. Tirasophon,W. et al. A stress response
pathway from the endoplasmicreticulum to
the nucleus requires
a novel bifunctional proteinkinase/endoribonuclease
(Ire1p) in mammalian cells. Genes Dev. 12,1812-1824(1998).
17. Wang,X-Z.et al. Cloning of mammalian
Ire1 reveals diversity in the ERstress responses.
EMBO J. 17, 5708-5717 (1998).
18. Katayama, T. et al. Presenilin-1 mutations
downregulate the signalling pathway of unfolded
protein response. Nature Cell Biol. in press
(1999).
19. Iwatsubo, T. et al. Purification and
characterization of Lewy bodiesfrom the brains
of patients with diffuse Lewy body disease.
Am.J.Pathol.148, 1517-1529 (1996).
20. DiFiglia,M. et al. Aggregation of huntingtin
in neuronal intranuclearinclusions and dystrophic
neurites in brain. $B!!(BScience 277, 1990-1993(1997).
References 3
1) Raff, M. C., Barres, B. A., Burne, J.
F., Coles, H. S., Ishizaki, Y., and Jacobson,
M. D. (1993)
Programmed cell death and the control of
cell survival: lessons from the nervous system.
Science, 262:695-700.
2) Purves, D.(1988) "Body and Brain"
Harverd University Press.
3) Levi-Montalcini, R. And Angeletti, P.
(1968)
Nerve growth factor, Pysiol. Rev., 48:534-569.
4) Cohen, S. And Levi-Montalcini, R. (1956)
A nerve growth-stimulating factor isolated
from snake venom. Proc. Natl. Acad Sci. USA,
42:571-574.
5) Johnson, E. M., Gorin, P. D., Brandeis,
L. D. And Pearson, J. (1980)
Science, 210:916-918.
6) Smeyne, R. J., Klein, R., Schnapp, A.,
Long, L. K., Bryant, S., Lewin, S. A. and
Barbacid, M. (1994)
Severe sensory and sympathetic neuropathies
in mice carrying a disrupted Trk/NGF. Nature,
368:246-248.
7) Davies, A. M., Enokido, Y. and Wyatt,
S.(1999)
Paradigms of neurotrophic factor action in
regulating neuronal survival in the developing
nervous system. Taniguchi Symposium, in press.
8) Davies, A. M., Bandtlow, C., Heumann,
R., Korsching, S., Rohrer, H. And Thoenen,
H. (1988)
Timing and site of nerve growth factor synthesis
in developing skin in relation to innervation
and expression of the receptor. Nature, 326:353-358.
9) Wyatt, S. And Davies, A. M.(1993)
Regulation of expression of mRNAs encoding
the nerve growth factor receptors p75 and
trkA in developing sensory neurons. Development,
119:635-648.
10) Buchman, V. L., and Davies, A. M.(1993)
Different neurotrophins are expressedand
act in a developmental sequence to promote
the survival of embryonic sensory neurons.
Development, 118: 989-1001.
11) Davies, A. M. (1997)
Neurotrophin switching: where does it stand?
Curr. Opin. Neurobiol.,7:110-118.
12) Verdi, J. M. And Anderson, D. J. (1994)
Neurotrophins regulate sequential changes
in neurotrophin receptor expression by sympathetic
neuroblasts.Neuron, 13:1359-1372.
13) Wang, H. And Tessier-Lavigne, M.(1999)
En passant neurotrophic action of and intermediate
axonal target in the developing mammalian
CNS. Nature, 401;765-769.
14) Davies , A. M. and Wright, E. M. (1995)
Neurotrophin autocrine loops. Curr. Biol.,
5:723-726.
15) ElShamy, W. M., Fridvall, L. K. and Ernfors,
P.(1998)
Growth arrest failure, G1 restriction point
override, and S phase death of sensory precursor
cells in the absence of neurotrophin-3.Neuron,
21:1003-15
16) Enokido, Y., Wyatt, S. and Davies, A.
M. (1999)
Developmental changes in the response of
trigeminal neurons to neurotrophins: influence
of birthdate and the ganglion environment.
Development, 126:4365-4373.
17) Ma, Q., Fode, C., Guillemot, F. and Anderson,
D. J.(1999)
NEUROGENIN1 and NEUROGENIN2 control two distinct
waves of neurogenesis in developing dorsal
root ganglia. Genes & Dev., 13:1717-1728.
18) Ma, Q., Chen, Z., del Barco Barrantes,
I., de la Pompa, J. L. and Anderson, D. J.
(1998)
Neurogenin1 is essential for the determination
of neuronal precursors for proximal cranial
sensory ganglia. Neuron, 20:469-82
19) Fode, C., Gradwohl, G., Morin, X., Dierich,
A., LeMeur, M., Goridis, C. and Guillemot,
F. (1998)
The bHLH protein NEUROGENIN 2 is a determination
factor for epibranchial placode-derived sensory
neurons. Neuron, 20:483-94
20) O'Connor, R. and Tessier-Lavigne, M.(1999)
Identification of maxillary factor, a maxillary
process-derived chemoattractant for developing
trigeminal sensory axons. Neuron, 24:165-178.
21) Lumsden, A. G., and Davies, A. M. (1983)
Earliest sinsory nerve fibers are guided
to peripheral targets by attractants other
than nerve growth factor. Nature,306:786-788.
22) Tessier-Lavigne, M., and Placzek, M.
(1991)
Target attraction: are developing axons guided
by chemotropism? Trends Neurosci., 14:303-310.
23) Blasschke, A. J., Staley, K. and Chun,
J.(1996)
Widespread programmed cell death in proliferative
and postmitotic regions of the fetal cerebral
cortex. Development, 122:1165-1174.
Dr. HIROYUKI OHYAMA$B!J(BPh.D$B!K(B in 1995.
Age-related difference in synaptosomal membrane
fluidity
Biochemistry and Molecular Biology International
37,133-140,1995
Hiroyuki Ohyama, Midori Hiramatsu, Norio
Ogawa, Akitane Mori
Department of Neuroscience, Institute of
Molecular and Cellular Medicine,
Okayama University Medical School, 2-5-1
Shikatacho, Okayama 700, Japan
and *Division of Medical Science, Institute
for Life Support Technology, Yamagata Technopolis
Foundation,
Yamagata 683 Kurumanomae, Numagi, Yamagata
990, Japan
$B!!!!(B
Age-related difference in synaptosomal membrane
fluidity
Biochemistry and Molecular Biology International
37,133-140,1995
Hiroyuki Ohyama, Midori Hiramatsu, Norio
Ogawa, Akitane Mori
Department of Neuroscience, Institute of
Molecular and Cellular Medicine,
Okayama University Medical School, 2-5-1
Shikatacho, Okayama 700, Japan
and *Division of Medical Science, Institute
for Life Support Technology, Yamagata Technopolis
Foundation,
Yamagata 683 Kurumanomae, Numagi, Yamagata
990, Japan
Dr. HIROYUKI OHYAMA$B!J(BPh.D$B!K(B in 1995.
sohhaku OHYAMA memorial
Oriental Medicine Museum
BIOCHEMISTRY & MOLECULAR BIOLOGY
HIGHER NERVOUS SYSTEM
KAMPO MEDICINE
Dr. HIROYUKI OHYAMA$B!J(B Ph.D$B!K(B in 1995.
$B4AJ}@lLg(B
$BBg;34AJ}F2Lt6I(B
$B!!(B$B!!(B
$BBg;34AJ}F2Lt6I(B
$B4AJ}7r9/AjCL%3!<%J!<$X!"%/%j%C%/!*(B
$B:4LnLq=|$1Bg;UDL$j$N4AJ}@lLg!"Bg;34AJ}F2Lt6I!!(BWeb-Page
$B$X!"#G#o!*!*!*(B
$B0eLtIJ$O;HMQ>e$NCm0U$r$*FI$_$$$?$@$-!"@5$7$/$*;H$$$/$@$5$$!#(B
$B$*Gc$$5a$a$N:]$K$O!"4AJ}$r8=BeIB$K3h$+$9(B $B4AJ}@lLg(B $BBg;34AJ}Lt6I$K!"$*5$7Z$K$4AjCL$/$@$5$$!#(B
$B!V%$%s%?!<%M%C%H$G8+$?!*!W(B
$B$H$*OC$/$@$5$$!#(B
$B!JCm0U!K(B
$B4AJ}@lLg!!Bg;34AJ}F2Lt6I$N!!87A*!"4AJ}Lt!"7r9/?)IJ$N$4CmJ8$O!"(B
$BBg;34AJ}Lt6I$K!"D>@\!"$*EEOC!"(BFAX$B!"(BE-mail $B$K$F$4MQL?$/$@$5$$!#(B
$B$*EEOC!'(B0283-22-1574$B!"(BFAX$B!'(B0283-22-1607$B!"(BE-mail:ohyama@poem.ocn.ne.jp
$B$*BT$ACW$7$F$*$j$^$9!#(B
$B!VBg;34AJ}F2(B $B4AJ}0e3X$H4AJ}7r9/AjCL!W(B
$B!!!!!!!!!!(B
$B!!Bg;34AJ}F2Lt6I$NF@0U$H$9$kIB5$!"Bg;34AJ}F2Lt6I$K4AJ}AjCL$N$"$k$4IB5$0lMw!"(B
$B!!!!Bg;34AJ}F2Lt6I(B $B4AJ}7r9/AjCLAk8}!"0e3XGn;NBg;3Gn9T@h@8!"0e3XGn;N>.>>Lw90@h@8$N$4>R2p(B
" THE KAMPO " $B4AJ}(B
$B!!4AJ}Lt(B, How the Japanese Updated Traditional
Herbal Medicine
$B!c4AJ}Lt$N$4I~MQ$r$*9M$($N3'MM$X$N$*4j$$!*!d(B
$B!v4AJ}Lt$N$4I~MQ$K4X$7$^$7$F$O!"(B
$B!V;HMQ>e$NCm0U!W$r$h$/FI$_!"!VMQK!!&MQNL!W$r$h$/
$B$^$?!":#2s!";O$a$F!"4AJ}Lt$N$4I~MQ$r4uK>$5$l$k$*5RMM$O!"(B
$B2<5-!"Ld?GI=$KI,MW;v9`$r5-F~$7$FAw?.$9$k$+!"(B
$B4AJ}AjCL$*?=$79~$_%U%)!<%`(B
$B$*EEOC$K$F!"D>@\!"Bg;34AJ}Lt6I$K!"$4AjCL$/$@$5$$!#(B
$B>I>u!&BN\$7$/$*;G$$$7$?>e$G!"E,@Z$J4AJ}Lt$r%"%I%P%$%9$5$;$FD:$-$^$9!#(B
$B!JBg;34AJ}Lt6I(B / $BL5NA4AJ}AjCLEEOC(B $B#0#2#8#3(B-$B#2#2(B-$B#1#5#7#4(B
/ $B#9!'#0#0!A#1#9!'#0#0!K(B
$B!cCm0U!d(B
$BBg;34AJ}Lt6I!"%G%8%?%kE9J^$G!"$*
$B0J>e!"$h$m$7$/$*4j$$CW$7$^$9!#(B
E-mail to Dr. Ohyama Kampo Pharmacy.
$B!V4AJ}@lLg!!Bg;34AJ}F2Lt6I!!87A*!!93%&%$%k%9:nMQ$r;}$D4AJ}Lt$r!"$I$&$>!"$43hMQ$/$@$5$$!#!W(B
$B!!4AJ}$r8=BeIB$K3h$+$9!*!!4AJ}@lLg!!Bg;34AJ}Lt6I%G%8%?%kE9J^$X!*(B
$BBg;34AJ}F2Lt6I(B $B")(B327-0026$B!!FJLZ8):4Ln;T6b20CgD9D.#2#4#3#2(B
TEL$B!u(BFAX : 0283-22-1574$B!!(B E-mail : ohyama@poem.ocn.ne.jp
$BBg;34AJ}F2Lt6I(B
$B")(B327-0026 $BFJLZ8):4Ln;T6b20CgD.#2#4#3#2HVCO(B
TEL: 0283-22-1574$B!JBg;34AJ}$G!"%$%4!&IT0B!&%J%7!K(B
TEL: 0283-22-1389$B!JBg;3o*5d$K!"%$%6!&%O%j%-%e%&!K(B
$B!!(B2021$B!!4AJ}Lt6I!!Bg;34AJ}F2Lt6I(B
$B!!(B$B!!(B
$B!V$d$C$Q$j!"4AJ}Lt$O!"87A*$5$l$?@8Lt$r!">I>u!"BN
$B!VCN<1$H7P83K-IY$J4AJ}@lLg!!Bg;34AJ}F2Lt6I$K!"0lEY$*EEOC$/$@$5$$!*!!#0#2#8#3(B-$B#2#2(B-$B#1#5#7#4!JBg;34AJ}$G!"%$%4!&IT0B!&%J%7!K!W(B
$B4AJ}Lt@lLg!!Bg;34AJ}F2Lt6I(B
$B")(B327-0026$B!!FJLZ8):4Ln;T6b20CgD.#2#4#3#2!!(BTEL: 0283-22-1574
E-mail to ohyama@poem.ocn.ne.jp
$BImO?(B
$BG'CN>I$K8z$/4AJ}Lt(B
$B2,;3Bg3X0e3XGn;N!!FAEgBg3XLt3X=$;N!!Bg;3Gn9TCx(B
$B!VG>$r
$B!!(B$B!!(B
$BG'CN>I$K8z$/4AJ}Lt(B
$BG'CN>I!JCTJr>I!K!&%"%k%D%O%$%^!pJsK~:\(B
$BG>$NO72=$H%\%1$N4X78$r$o$+$j$d$9$/2r@b(B
$B:G?72J3X$GZ$5$l$?4AJ}Lt$N8z2L$r0lHL$N?M$K$b$o$+$j$d$9$/>R2p(B
$BC/$K$G$b$G$-$k%\%1M=KI$N#6%v>r$r>R2p(B
$BDj2A!!!o(B860- [$B@G9~(B]
$B!VG>$r